Greenland Mines Ltd
Greenland Mines develops medicines for chronic diseases, including cancer, cardiovascular disorders and neurodegenerative diseases. Its platforms include licensed generic drugs and biosimilar biologics, as well as a proprietary gene therapy platform that aims to produce the Klotho protein in the body. Its lead gene therapy candidates target Alzheimer’s disease and amyotrophic lateral sclerosis. The company also holds licenses for biosimilar antibodies used in cancer treatment and acquired market authorizations for anti-cancer drugs approved for sale in Germany. In March 2026, Greenland Mines completed its acquisition of Greenland Mines Corp., expanding into the development and mining of critical and precious minerals. Greenland Mines may develop its technologies or sell, partner or out-license them. It also plans to develop an assay to measure Klotho protein forms, with the possibility of offering it as a commercial diagnostic if it becomes a clinical biomarker. The company is headquartered in Omaha, Nebraska.
No SEC Form 4 filings for $GRML in the last 30 days.
See all $GRML insider activity →Greenland Mines Ltd (GRML) increased its stake in AnorTech Inc. (ANOR) to 19.9% by acquiring 25.17 million shares at C$0.30 per share, totaling C$7.55 million. The deal involved issuing 1.13 million GRML shares. GRML may adjust its stake based on market conditions and ANOR's prospects, with a 60-month lock-up period on the acquired shares.
Greenland Mines Ltd (Nasdaq: GRML) welcomed the Greenland Parliament's approval of a U.S.-Denmark-Greenland security agreement, highlighting its Sarfartoq rare earths and Skaergaard precious metals projects as potential contributors to secure allied supply chains. The agreement was approved 16–0 with seven abstentions and is expected to undergo further consideration in Denmark.
Greenland Mines Ltd (Nasdaq: GRML) has started trading its shares on Xetra, Deutsche Börse's electronic trading platform, in addition to its existing Nasdaq listing. This move aims to broaden the company's investor base and increase liquidity by connecting with European, Asian, and Middle Eastern markets. The company remains a U.S. issuer with Nasdaq as its principal market.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning GRML (Greenland Mines Ltd). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent GRML coverage spans financial news, corporate actions and market movers.
The stake increase signals confidence in AnorTech and expands Greenland's exposure to critical minerals, likely supporting GRML's share price.
The approval may enhance the company's strategic positioning and attract investor interest.
The new Xetra listing expands the investor base and may improve liquidity, potentially supporting a modest price appreciation.
Significant rally as investors anticipate increased demand for palladium, gold and platinum projects.
Momentum‑driven upside expected as the rare‑earth story fuels buying pressure.
AlphAI scores every news story that mentions GRML with an AI model for sentiment and relevance, and aggregates insider trades from Greenland Mines Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Greenland Mines Ltd (GRML) increased its stake in AnorTech Inc. (ANOR) to 19.9% by acquiring 25.17 million shares at C$0.30 per share, totaling C$7.55 million. The deal involved issuing 1.13 million GRML shares. GRML may adjust its stake based on market conditions and ANOR's prospects, with a 60-month lock-up period on the acquired shares.
Greenland Mines Ltd (Nasdaq: GRML) welcomed the Greenland Parliament's approval of a U.S.-Denmark-Greenland security agreement, highlighting its Sarfartoq rare earths and Skaergaard precious metals projects as potential contributors to secure allied supply chains. The agreement was approved 16–0 with seven abstentions and is expected to undergo further consideration in Denmark.
Greenland Mines Ltd (Nasdaq: GRML) has started trading its shares on Xetra, Deutsche Börse's electronic trading platform, in addition to its existing Nasdaq listing. This move aims to broaden the company's investor base and increase liquidity by connecting with European, Asian, and Middle Eastern markets. The company remains a U.S. issuer with Nasdaq as its principal market.
Greenland-linked stocks surged premarket after President Trump posted about 'massive' oil, gas, and mineral exploration on the island. Greenland Energy (GLND) rose 90.08% to $4.20, Greenland Mines (GRML) gained 43.50% to $7.95, and Critical Metals (CRML) increased 4.61% to $6.84. Trump's post cited experts claiming Greenland's oil supply is among the world's largest.
Greenland Mines Ltd (GRML) shares surged 38.99% on October 14, 2026, following a new rare-earth discovery and a U.S.-Denmark-Greenland security pact. The company is pre-revenue with a net loss of $3.69M in Q2 2026, but traders are focused on its potential in rare earth minerals. GRML's stock has shown significant volatility, with shares rising from $9.42 to $17.99 before falling to $5.54.
The EU selected Neo Performance Materials' Silmet 2.0 plan as a Strategic Project under the Critical Raw Materials Act. Greenland Mines, a strategic partner of Neo, holds rights to up to 60% of a Greenland project's output. The selection highlights the importance of diversified, geopolitically aligned rare earth supply chains, benefiting Greenland Mines' Sarfartoq project.
Greenland Mines Ltd (GRML) shares fell 12.9% after a $42M offering and Frankfurt debut. The company has no revenue, negative profitability, and heavy cash burn. Analysts note weak book value, high dilution risk, and a short-term downtrend. Key support levels are 4.50–4.75, with resistance at 6.30.
Greenland Mines (GRML, HK6) announced its President will participate in the 2026 Arctic Circle Assembly, discussing its Sarfartoq and Skaergaard projects. The Sarfartoq project has a pre-tax NPV of $2.05B, and the Skaergaard project recently completed drilling. The company aims to connect Greenland's mineral resources with global markets.
Greenland Mines (GRML) completed its acquisition of Sarfartoq and advanced drilling and exploration. Analyst Jack Lifton highlighted GRML's position in Greenland's rare earth sector, crucial for reducing reliance on Chinese supply. The company's Sarfartoq project is key to its strategy in this growing market.
Greenland Mines (GRML) authorized a $20M share buyback program, following a $59M capital raise. The company plans open-market repurchases based on market conditions. GRML stock fell 14.44% Tuesday, with a market cap of $84.44M. The company focuses on its Sarfartoq and Skaergaard projects.
